RedHill Biopharma

#Biopharma #Pharmaceutical #RedHill Biopharma

Cumberland Pharmaceuticals invests $4 million in Talicia

Specialty pharmaceuticals company Cumberland Pharmaceuticals has invested $4 million in Talicia, the global product developed by biopharmaceutical company RedHill Biopharma.  Talicia is the number one branded US gastroenterologist-prescribed H. pylori therapy, listed as a first-line H. pylori therapy in American College of Gastroenterology Clinical Guidelines. It remains the only FDA-approved all-in-one, low-dose rifabutin-based H. pylori therapy… Read More

#Business & Investment #News

Obese man measures his waist
#Diabetes #Obesity #RedHill Biopharma #Weight loss

Studies support potential treatment for obesity-related disorders

Positive results from multiple in vivo studies have shown the impact of sphingosine kinase-2 (SPHK2) inhibition in various models of metabolic disease. RedHill Biopharma announced the positive study results, which show the effect of opaganib on weight gain and glucose tolerance in a high fat diet… Read More

#News